Skip to main content
Premium Trial:

Request an Annual Quote

Maybe Pharma Could Use a Bill Gates

Bill Gates is stepping down as head of Microsoft in less than three months, and he has big plans for how he's going to spend his time, says this post at Wired. At a speech on Monday at the Institute for Systems Biology, Gates told the crowd that he would devote his full energy to his foundation and to encouraging technology and biology to get pharma to develop more drugs for infectious diseases in the developing world. (Still no change on his disfavor of open source software, though.)

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.